|
|
Rue Pierre et Marie CURIE - BP 28 262
LABEGE INNOPOLE, 31 682 France
phone:+33 561 287 040
fax:+33 561 287 043
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.physiogenex.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Defining and validating drug compounds and target genes in obesity, diabetes, and similar fields. |
|
| Management |
| Guillaume P. Costecalde, Founder, Chairman and CEO; Thierry Sulpice PhD, Founder, CSO; Delphine PUERTOLAS, Founder, Director of Regulatory Affairs; Franois BRIAND PhD, Project Manager; Bndicte Prunet-Marcassus PhD, Project Manager
|
| |
|
|
| |
|
| Keywords |
| biotechnology, compounds, targets, in vivo, technologies, drug, genes, obesity, Diabetes, blood sugar, diabetic, metabolic, insulin |
|
|
|
| Description |
|
Physiogenex specializes in functional validation of lead compounds and new therapeutic targets. The company has expertise in defining and validating drug compounds and tomorrows target genes in obesity, diabetes and associated complications fields. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members